<DOC>
	<DOCNO>NCT00370500</DOCNO>
	<brief_summary>BACKGROUND : Epigenetic modification DNA-methylation histone acetylation know involved pathophysiology schizophrenia . Aim present study investigate 1. whether difference methylation pattern promoter dopaminergic gene exist schizophrenic patient healthy control 2. whether treatment second generation antipsychotic quetiapine lead change methylation pattern gene patient suffer schizophrenia . STUDY DESIGN AND METHODS : 50 male patient 50 male control enrol study . Patients treat quetiapine 3 week . Blood sample draw treatment three week measure DNA-methylation status . Clinical characterisation include PANSS , AIMS , BDI . Healthy probands treat .</brief_summary>
	<brief_title>Quetiapine Dopaminergic Epigenetic Control</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Dopamine</mesh_term>
	<mesh_term>Dopamine Agents</mesh_term>
	<mesh_term>Dopamine Agonists</mesh_term>
	<criteria>Inclusion criterion : For inclusion study subject must fulfil follow criterion : 1 . Provision write informed consent 2 . A diagnosis schizophrenia Diagnostic Statistical Manual Mental Disorders Fourth Edition ( DSMIV ) 3 . Able understand comply requirement study 4 . Age 18 65 year Exclusion criterion : Any follow regarded criterion exclusion study : 1 . Any DSMIV Axis I disorder define inclusion criterion 2 . Patients , opinion investigator , pose imminent risk suicide danger self others 3 . Known intolerance lack response quetiapine fumarate , judge investigator 4 . Use follow cytochrome P450 3A4 inhibitor 14 day precede enrolment include limited : ketoconazole , itraconazole , fluconazole , erythromycin , clarithromycin , troleandomycin , indinavir , nelfinavir , ritonavir , fluvoxamine saquinavir 5 . Use follow cytochrome P450 inducer 14 day precede enrollment include limited : phenytoin , carbamazepine , barbiturate , rifampin , St. John 's Wort , glucocorticoids 6 . Administration depot antipsychotic injection within one dose interval ( depot ) inclusion 7 . Substance alcohol dependence enrolment ( except dependence full remission , except caffeine nicotine dependence ) , define DSMIV criterion 8 . Opiates , amphetamine , barbiturate , cocaine , cannabis , hallucinogen abuse DSMIV criterion within 4 week prior enrolment 9 . Medical condition would affect absorption , distribution , metabolism , excretion study treatment 10 . Unstable inadequately treat medical illness ( e.g . diabetes , angina pectoris , hypertension ) judge investigator 11 . Involvement plan conduct study 12 . Previous enrolment present study . 13 . Participation another drug trial within 4 week prior enrolment study long accordance local requirement 14 . Actual treatment clozapine clozapine treatment previous three month . Other antipsychotic drug allow , intake terminate two day wash period . 15 . Previous history major head injury neurological disorder 16 . Intake homocysteine lower vitamin ( folate , B12 , B6 ) 17 . Renal failure 18 . Intake nutritional derivative influence epigenetic pattern ( butyrate milk product , tea polyphenol epigallocatechin3gallate inhibits DNMT )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Dopamine transporter gene</keyword>
	<keyword>DNA methylation</keyword>
	<keyword>Epigenetics</keyword>
</DOC>